Skip to main content
Equibles
SRTA logo

SRTA · Strata Critical Medical, Inc. · Metrics

Track SRTA — free

Use SRTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SRTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.27 +0.05 (+0.94%)
Russell 2000 member Rebalance outlook locked
Market Cap
$461.80M
Shares
88.47M

SRTA metrics

68 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.22
Market cap
$461.80M

Price action

20 metrics
Price change (1W)
-1.1%
Price change (30D)
-10.6%
Price change (3M)
-5.3%
Price change (6M)
+14.2%
Price change (YTD)
+10.4%
Price change (1Y)
+32.8%
Trailing year
Price change (5Y)
-39.6%
52-week high
$6.47
52-week low
$3.99
Change from 52-week high
-17.9%
Change from 52-week low
+33.1%
Annualized volatility
59.6%
Annualized volatility (3M)
49.1%
Beta
2.2
RSI (14D)
39.8
Price vs SMA 50
-3.3%
Price vs SMA 200
+4.2%
Avg volume (3M)
1.15M
Relative volume
0.8
Average dollar volume
$6.34M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
88.47M

Valuation

12 metrics
P / E (TTM)
10.6
Trailing earnings · reciprocal yield 9.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 54.4%
P / book
1.7
reciprocal yield 59.3%
FCF yield
-10.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
8.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 87.1%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 87.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
20.9%
Operating margin
-8.0%
Trailing 12 months
Net margin
15.7%
Gross profit (TTM)
$54.40M
Operating profit (TTM)
−$20.41M
Net income (TTM)
$40.22M
Trailing 12 months
Diluted EPS (TTM)
$0.50
FCF margin
-18.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+60.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$255.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.0%
Year over year · more shares
Revenue CAGR (3Y)
+10.5%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
14.4%
Return on assets
12.1%
Debt / equity
—
Current ratio
2.6
EBITDA (TTM)
−$4.12M
Free cash flow (TTM)
−$48.45M
Quick ratio
2.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$16.32M
Total assets
$332.70M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$36.03M
Capital expenditures (TTM)
$12.41M
R&D (TTM)
$3.31M
SG&A (TTM)
$64.85M
Stock compensation (TTM)
$17.01M
R&D / revenue
—
Stock compensation / revenue
6.6%

Ownership (13F)

3 metrics
13F filers
140
13F filer change QoQ
+14
Institutional ownership
61.2%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$29,273
Insider-sentiment score
54 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1779128 CUSIP 092667104 13F (30d) 91 filings 91 filers Visit website Investor relations